Equitable Holdings’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
EP
IA
Equitable Holdings's AZN Position: Q2 2026 in Review
Equitable Holdings increased its AstraZeneca (AZN) stake by 46% in Q2 2026, buying an estimated $1.32M and bringing the position to 22,135 shares worth $4.2M. The position accounts for 0.03% of the portfolio, ranked #506.
Equitable Holdings first reported a position in AZN in Q3 2021 and has held it in 20 quarters since. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- Equitable Holdings held 22,135 shares of AstraZeneca worth $4.2M as of Q2 2026.
- Equitable Holdings bought 7,007 AstraZeneca shares in Q2 2026, an estimated $1.32M.
- AstraZeneca made up 0.03% of Equitable Holdings's portfolio in Q2 2026, its #506 holding.
- Equitable Holdings first reported a position in AstraZeneca in Q3 2021 and has held it in 20 quarters since.
- 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on Equitable Holdings's 13F filing for Q2 2026, filed 17 Aug 2026.